Graham Parry

Person

South San Francisco, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Anti-complement C1s antibodies and uses thereof
- Patent number 12,240,917
- Issue date Mar 4, 2025
- Bioverativ USA Inc.
- Peter Van Vlasselaer
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Anti-complement C1s antibodies and uses thereof
- Patent number 12,215,169
- Issue date Feb 4, 2025
- Bioverativ USA Inc.
- Peter Van Vlasselaer
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Humanized anti-complement factor Bb antibodies and uses thereof
- Patent number 11,999,780
- Issue date Jun 4, 2024
- Genzyme Corporation
- Graham Parry
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-complement factor Bb antibodies and uses thereof
- Patent number 11,851,482
- Issue date Dec 26, 2023
- Genzyme Corporation
- Sandip Panicker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Polynucleotides encoding anti-C1s antibodies
- Patent number 11,246,926
- Issue date Feb 15, 2022
- Bioverativ USA Inc.
- Sandip Panicker
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Humanized anti-complement factor Bb antibodies
- Patent number 11,242,382
- Issue date Feb 8, 2022
- Genzyme Corporation
- Graham Parry
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of inducing complement activity
- Patent number 11,192,944
- Issue date Dec 7, 2021
- Bioverativ USA Inc.
- Sandip Panicker
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-complement factor BB antibodies and uses thereof
- Patent number 10,934,347
- Issue date Mar 2, 2021
- Genzyme Corporation
- Sandip Panicker
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Humanized anti-C1s antibodies and methods of inhibiting C1s cleavage
- Patent number 10,729,767
- Issue date Aug 4, 2020
- Bioverativ USA Inc.
- Sandip Panicker
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-complement C1s antibodies
- Patent number 10,457,745
- Issue date Oct 29, 2019
- Bioverativ USA Inc.
- Peter Van Vlasselaer
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Anti-complement C1s antibodies
- Patent number 10,450,382
- Issue date Oct 22, 2019
- Bioverativ USA Inc.
- Peter Van Vlasselaer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tau peptides, anti-tau antibodies, and methods of use thereof
- Patent number 10,400,018
- Issue date Sep 3, 2019
- iPierian, Inc.
- Irene Griswold-Prenner
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-complement C1s antibodies and methods of inhibiting complement...
- Patent number 9,562,106
- Issue date Feb 7, 2017
- True North Therapeutics, Inc.
- Peter Van Vlasselaer
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of inhibiting complement C4 activation with anti-complement...
- Patent number 9,562,092
- Issue date Feb 7, 2017
- True North Therapeutics, Inc.
- Peter Van Vlasselaer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-complement C1s antibodies and methods of inhibiting complement...
- Patent number 9,512,233
- Issue date Dec 6, 2016
- True North Therapeutics, Inc.
- Peter Van Vlasselaer
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of inhibiting complement C4 activation with anti-complement...
- Patent number 9,206,259
- Issue date Dec 8, 2015
- True North Therapeutics, Inc.
- Peter Van Vlasselaer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of inhibiting activation of complement component C4 with an...
- Patent number 9,074,003
- Issue date Jul 7, 2015
- True North Therapeutics, Inc.
- Peter Van Vlasselaer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of inhibiting activation of complement component C4 with an...
- Patent number 9,074,004
- Issue date Jul 7, 2015
- True North Therapeutics, Inc.
- Peter Van Vlasselaer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-complement C1s antibodies
- Patent number 8,945,562
- Issue date Feb 3, 2015
- True North Therapeutics, Inc.
- Peter Van Vlasselaer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-complement C1s
- Patent number 8,877,197
- Issue date Nov 4, 2014
- True North Therapeutics, Inc.
- Peter Van Vlasselaer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Urokinase-type plasminogen activator receptor epitope, monoclonal a...
- Patent number 8,105,602
- Issue date Jan 31, 2012
- Tactic Pharma, LLC
- Graham Parry
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Ligands binding the complex of urokinase-type plasminogen activator...
- Patent number 8,101,726
- Issue date Jan 24, 2012
- Tactic Pharma, LLC
- Graham C. Parry
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
ANTI-COMPLEMENT C1S ANTIBODIES AND USES THEREOF
- Publication number 20250188192
- Publication date Jun 12, 2025
- Bioverativ USA Inc.
- Peter Van Vlasselaer
- A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING
Information Patent Application
METHODS FOR TREATING COMPLEMENT-MEDIATED DISEASES AND DISORDERS
- Publication number 20250145696
- Publication date May 8, 2025
- Bioverativ USA Inc.
- Peter Van Vlasselaer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMANIZED ANTI-COMPLEMENT FACTOR BB ANTIBODIES AND USES THEREOF
- Publication number 20240391986
- Publication date Nov 28, 2024
- Genzyme Corporation
- Graham Parry
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-COMPLEMENT FACTOR BB ANTIBODIES AND USES THEREOF
- Publication number 20240228599
- Publication date Jul 11, 2024
- Genzyme Corporation
- Sandip Panicker
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-C1S ANTIBODIES AND METHODS OF USE THEREOF
- Publication number 20240076363
- Publication date Mar 7, 2024
- Bioverativ USA Inc.
- Sandip Panicker
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HUMANIZED ANTI-C1S ANTIBODIES AND METHODS OF USE THEREOF
- Publication number 20230218753
- Publication date Jul 13, 2023
- Bioverativ USA Inc.
- Sandip PANICKER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING AUTOIMMUNE AND ALLOIMMUNE DISORDERS
- Publication number 20220249664
- Publication date Aug 11, 2022
- Bioverativ USA Inc.
- Graham Parry
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMANIZED ANTI-COMPLEMENT FACTOR BB ANTIBODIES AND USES THEREOF
- Publication number 20220213179
- Publication date Jul 7, 2022
- Genzyme Corporation
- Graham Parry
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-COMPLEMENT C1S ANTIBODIES AND USES THEREOF
- Publication number 20220204647
- Publication date Jun 30, 2022
- Bioverativ USA Inc.
- Peter Van Vlasselaer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-COMPLEMENT C1S ANTIBODIES AND USES THEREOF
- Publication number 20220185912
- Publication date Jun 16, 2022
- Bioverativ USA Inc.
- Peter Van Vlasselaer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMANIZED ANTI-COMPLEMENT FACTOR BB ANTIBODIES AND USES THEREOF
- Publication number 20210332115
- Publication date Oct 28, 2021
- Genzyme Corporation
- Graham Parry
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-COMPLEMENT FACTOR BB ANTIBODIES AND USES THEREOF
- Publication number 20210221877
- Publication date Jul 22, 2021
- Bioverativ USA Inc.
- Sandip Panicker
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS FOR TREATING COMPLEMENT-MEDIATED DISEASES AND DISORDERS
- Publication number 20210115116
- Publication date Apr 22, 2021
- Bioverativ USA Inc.
- Peter Van Vlasselaer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMANIZED ANTI-C1S ANTIBODIES AND METHODS OF USE THEREOF
- Publication number 20200405852
- Publication date Dec 31, 2020
- Bioverativ USA Inc.
- Sandip PANICKER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF INDUCING COMPLEMENT ACTIVITY
- Publication number 20200239556
- Publication date Jul 30, 2020
- Bioverativ USA Inc.
- Sandip Panicker
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Methods of Treating a Tauopathy
- Publication number 20200102375
- Publication date Apr 2, 2020
- IPIERIAN, INC.
- Irene Griswold-Prenner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-COMPLEMENT C1S ANTIBODIES AND USES THEREOF
- Publication number 20200079875
- Publication date Mar 12, 2020
- Bioverativ USA Inc.
- Peter Van Vlasselaer
- A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING
Information Patent Application
ANTI-COMPLEMENT C1S ANTIBODIES AND USES THEREOF
- Publication number 20200079876
- Publication date Mar 12, 2020
- Bioverativ USA Inc.
- Peter Van Vlasselaer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-C1S ANTIBODIES AND METHODS OF USE THEREOF
- Publication number 20200048332
- Publication date Feb 13, 2020
- Bioverativ USA Inc.
- Sandip Panicker
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-COMPLEMENT FACTOR BB ANTIBODIES AND USES THEREOF
- Publication number 20190153079
- Publication date May 23, 2019
- Bioverativ USA Inc.
- Sandip Panicker
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS OF TREATING AUTOIMMUNE AND ALLOIMMUNE DISORDERS
- Publication number 20180169240
- Publication date Jun 21, 2018
- Bioverativ USA Inc.
- Graham PARRY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMANIZED ANTI-C1S ANTIBODIES AND METHODS OF USE THEREOF
- Publication number 20180092974
- Publication date Apr 5, 2018
- Bioverativ USA Inc.
- Sandip PANICKER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-COMPLEMENT C1S ANTIBODIES AND USES THEREOF
- Publication number 20170226230
- Publication date Aug 10, 2017
- TRUE NORTH THERAPEUTICS, INC.
- Peter Van Vlasselaer
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTI-COMPLEMENT C1S ANTIBODIES AND USES THEREOF
- Publication number 20170226229
- Publication date Aug 10, 2017
- TRUE NORTH THERAPEUTICS, INC.
- Peter Van Vlasselaer
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TAU PEPTIDES, ANTI-TAU ANTIBODIES, AND METHODS OF USE THEREOF
- Publication number 20160347804
- Publication date Dec 1, 2016
- IPIERIAN, INC.
- Irene GRISWOLD-PRENNER
- G01 - MEASURING TESTING
Information Patent Application
METHODS OF TREATING A TAUOPATHY
- Publication number 20160289309
- Publication date Oct 6, 2016
- IPIERIAN, INC.
- Irene GRISWOLD-PRENNER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-COMPLEMENT C1S ANTIBODIES AND USES THEREOF
- Publication number 20160053002
- Publication date Feb 25, 2016
- TRUE NORTH THERAPEUTICS, INC.
- Peter Van Vlasselaer
- A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING
Information Patent Application
ANTI-COMPLEMENT C1S ANTIBODIES AND USES THEREOF
- Publication number 20150329645
- Publication date Nov 19, 2015
- TRUE NORTH THERAPEUTICS, INC.
- Peter Van Vlasselaer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-COMPLEMENT C1S ANTIBODIES AND USES THEREOF
- Publication number 20150307626
- Publication date Oct 29, 2015
- TRUE NORTH THERAPEUTICS, INC.
- Peter Van Vlasselaer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-COMPLEMENT C1S ANTIBODIES AND USES THEREOF
- Publication number 20150259437
- Publication date Sep 17, 2015
- TRUE NORTH THERAPEUTICS, INC.
- Peter Van Vlasselaer
- C07 - ORGANIC CHEMISTRY

Graham Parry

Person

Patents Grantslast 30 patents

Anti-complement C1s antibodies and uses thereof

Anti-complement C1s antibodies and uses thereof

Humanized anti-complement factor Bb antibodies and uses thereof

Anti-complement factor Bb antibodies and uses thereof

Polynucleotides encoding anti-C1s antibodies

Humanized anti-complement factor Bb antibodies

Methods of inducing complement activity

Anti-complement factor BB antibodies and uses thereof

Humanized anti-C1s antibodies and methods of inhibiting C1s cleavage

Anti-complement C1s antibodies

Anti-complement C1s antibodies

Tau peptides, anti-tau antibodies, and methods of use thereof

Anti-complement C1s antibodies and methods of inhibiting complement...

Methods of inhibiting complement C4 activation with anti-complement...

Anti-complement C1s antibodies and methods of inhibiting complement...

Methods of inhibiting complement C4 activation with anti-complement...

Methods of inhibiting activation of complement component C4 with an...

Methods of inhibiting activation of complement component C4 with an...

Anti-complement C1s antibodies

Anti-complement C1s

Urokinase-type plasminogen activator receptor epitope, monoclonal a...

Ligands binding the complex of urokinase-type plasminogen activator...

Patents Applicationslast 30 patents

ANTI-COMPLEMENT C1S ANTIBODIES AND USES THEREOF

METHODS FOR TREATING COMPLEMENT-MEDIATED DISEASES AND DISORDERS

HUMANIZED ANTI-COMPLEMENT FACTOR BB ANTIBODIES AND USES THEREOF

ANTI-COMPLEMENT FACTOR BB ANTIBODIES AND USES THEREOF

ANTI-C1S ANTIBODIES AND METHODS OF USE THEREOF

HUMANIZED ANTI-C1S ANTIBODIES AND METHODS OF USE THEREOF

METHODS OF TREATING AUTOIMMUNE AND ALLOIMMUNE DISORDERS

HUMANIZED ANTI-COMPLEMENT FACTOR BB ANTIBODIES AND USES THEREOF

ANTI-COMPLEMENT C1S ANTIBODIES AND USES THEREOF

ANTI-COMPLEMENT C1S ANTIBODIES AND USES THEREOF

HUMANIZED ANTI-COMPLEMENT FACTOR BB ANTIBODIES AND USES THEREOF

ANTI-COMPLEMENT FACTOR BB ANTIBODIES AND USES THEREOF

METHODS FOR TREATING COMPLEMENT-MEDIATED DISEASES AND DISORDERS

HUMANIZED ANTI-C1S ANTIBODIES AND METHODS OF USE THEREOF

METHODS OF INDUCING COMPLEMENT ACTIVITY

Methods of Treating a Tauopathy

ANTI-COMPLEMENT C1S ANTIBODIES AND USES THEREOF

ANTI-COMPLEMENT C1S ANTIBODIES AND USES THEREOF

ANTI-C1S ANTIBODIES AND METHODS OF USE THEREOF

ANTI-COMPLEMENT FACTOR BB ANTIBODIES AND USES THEREOF

METHODS OF TREATING AUTOIMMUNE AND ALLOIMMUNE DISORDERS

HUMANIZED ANTI-C1S ANTIBODIES AND METHODS OF USE THEREOF

ANTI-COMPLEMENT C1S ANTIBODIES AND USES THEREOF

ANTI-COMPLEMENT C1S ANTIBODIES AND USES THEREOF

TAU PEPTIDES, ANTI-TAU ANTIBODIES, AND METHODS OF USE THEREOF

METHODS OF TREATING A TAUOPATHY

ANTI-COMPLEMENT C1S ANTIBODIES AND USES THEREOF

ANTI-COMPLEMENT C1S ANTIBODIES AND USES THEREOF

ANTI-COMPLEMENT C1S ANTIBODIES AND USES THEREOF

ANTI-COMPLEMENT C1S ANTIBODIES AND USES THEREOF